BTIG Reiterates Buy Rating on DexCom (DXCM)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil rises as Trump repeats Iran attack threat
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
DexCom (DXCM) PT Raised to $86 at Bernstein SocGen Group
October 25, 2024 6:25 AM EDTBernstein SocGen Group analyst Lee Hambright raised the price target on DexCom (NASDAQ: DXCM) to $86.00 (from $82.00) while maintaining a Market Perform rating.
The analyst comments "In-line quarter. Revenue grew 3% organic, landing at the high-end of the reduced guidance range that DXCM set on the Q2 call (1% to 3%). U.S. sales declined -2% organic,... More
After-hours movers: Capri Holdings, Skechers, DexCom, Western Digital and more
October 24, 2024 4:42 PM EDTAfter-Hours Stock Movers:
Capri Holdings (NYSE: CPRI) shares fell 48% after a judge blocked its deal to merge with Tapestry (NYSE: TPR), a victory for the FTC. Tapestry shares gained.
DexCom (NASDAQ:... More
DexCom Q3 earnings beat estimates, but stock tumbles 16% on weak growth
October 24, 2024 4:16 PM EDTDexCom (NASDAQ: DXCM) reported third-quarter earnings that surpassed analyst expectations, but the company's stock plummeted 16% as revenue growth slowed significantly.
The continuous glucose monitoring systems maker posted adjusted earnings per share of $0.45, beating the analyst consensus of $0.43. Revenue for the quarter came in at... More
DexCom (DXCM) Tops Q3 EPS by 2c, Maintains Guidance
October 24, 2024 4:04 PM EDTDexCom (NASDAQ: DXCM) reported Q3 EPS of $0.45, $0.02 better than the analyst estimate of $0.43. Revenue for the quarter came in at $994.2 million versus the consensus estimate of $990.44 million.
GUIDANCE:
DexCom sees FY2024 revenue of $4-4.05 billion, versus the consensus of $4.01... More
